Calamos Advisors’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Calamos Advisors’s Portfolio AMSGP Stock Details AMSGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-185,597	Closed	-$23.3M	–	697
2016 Q3	$23.3M	Sell	185,597 -30,005	-14%	-$3.9M	0.17%	182
2016 Q2	$31.1M	Sell	215,602 -786	-0.4%	-$114K	0.22%	146
2016 Q1	$30.5M	Sell	216,388 -611	-0.3%	-$82.2K	0.2%	156
2015 Q4	$31.2M	Sell	216,999 -21,440	-9%	-$3.23M	0.2%	156
2015 Q3	$35.3M	Sell	238,439 -10,202	-4%	-$1.55M	0.24%	132
2015 Q2	$34.7M	Buy	248,641 +45,791	+23%	+$6.09M	0.21%	143
2015 Q1	$25.3M	Buy	+202,850	New	+$24.2M	0.16%	173

Calamos Advisors's AMSGP Position: Q4 2016 in Review

Calamos Advisors sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 185,597 shares — an estimated $23.3M sold.

Calamos Advisors first reported a position in AMSGP in Q1 2015 and held it in 7 quarters. The position peaked at $35.3M in Q3 2015. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

Calamos Advisors reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
Calamos Advisors sold 185,597 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $23.3M.
Calamos Advisors first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q1 2015 and held it in 7 quarters.
Calamos Advisors's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $35.3M in Q3 2015.
0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on Calamos Advisors's 13F filing for Q4 2016, filed 6 Feb 2017.